C-8813
Jump to navigation
Jump to search
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C20H26BrNOS |
Molar mass | 408.40 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
C-8813 (thiobromadol) is a potent μ-opioid receptor agonist with a distinctive chemical structure which is not closely related to other established families of opioid drugs. The trans-isomer was found to be around 591 times more potent than morphine in animal studies.[1] The same study assigned a potency of 504 times that of morphine to the related compound BDPC.
C-8813 is claimed to be similarly potent at the δ-opioid receptor, which antagonizes the μ-induced depression of breathing, presumably making the drug safer.[1]
C-8813 has never been approved for use in humans.[citation needed]
See also
References
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed CASNo identifier
- Articles with changed ChemSpider identifier
- Articles with changed InChI identifier
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- All articles with unsourced statements
- Articles with unsourced statements from October 2023
- Arylcyclohexylamines
- Synthetic opioids
- Thiophenes
- Tertiary alcohols
- Bromobenzene derivatives
- Mu-opioid receptor agonists
- Delta-opioid receptor agonists
- All stub articles
- Analgesic stubs